# A Pharmacokinetic Study of SID1903 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult Volunteers

> **NCT05236998** · PHASE1 · COMPLETED · sponsor: **SK Chemicals Co., Ltd.** · enrollment: 45 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** SID1903 (FDC)
- **DRUG:** Dapagliflozin and Sitagliptin

## Key facts

- **NCT ID:** NCT05236998
- **Lead sponsor:** SK Chemicals Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-03
- **Primary completion:** 2021-12-21
- **Final completion:** 2021-12-31
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2022-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05236998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05236998, "A Pharmacokinetic Study of SID1903 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05236998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*